CD274 and neoplasm: The expression of PD‐1/PD‐L1 was significantly increased in patients treated with TACE by immunohistochemical analysis, and lenvatinib could reverse the increase of immunosuppressive cell types, such as tumor‐associated macrophages, myeloid‐derived suppressor cells, regulatory T cells, and so on.